Data / Form D filings / Escalier Biosciences B.V.
Escalier Biosciences B.V.: Form D filing
Escalier Biosciences B.V., a biotechnology company in Nijmegen, Netherlands, filed a Form D with the SEC in 2017. The latest, on March 20, 2017, reports $3.5 million sold of a $15.5 million offering to 5 investors.
Find out what Escalier Biosciences B.V. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- TRANSISTORWEG 5J, Nijmegen, Netherlands, 6534
- Phone
- (858) 945-2393
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Netherlands
- Year incorporated
- 2016
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1701386
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 20, 2017 | New notice | $15,500,000 | $3,500,000 | $12,000,000 | 5 | Feb 28, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Christopher Krueger | Executive Officer | |
| Somasundaram Subramaniam | Director | |
| E.C.M. van Wezel | Director | |
| Raju Mohan | Director |
Every Form D from the week of Mar 20, 2017 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Escalier Biosciences B.V. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.